Given that CXCR4 mediates the trafficking of breast and non-small cell lung cancer cells in an organ-specific manner [4,5,8], we hypothesized that there would be an increase in the number of RCC cells in circulation in patients with mRCC, and that these cells would express CXCR4. Here, CXCR4 is linked to renal cell adenocarcinoma.